25. Progressive multifocal leukoencephalopathy
23 clinical trials,   33 drugs   (DrugBank: 20 drugs),   7 drug target genes,   36 drug target pathways

Searched query = "Progressive multifocal leukoencephalopathy", "PML", "Leukoencephalopathy, progressive multifocal"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00120367
(ClinicalTrials.gov)
April 200511/7/2005Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)Early Intensification of Combination Antiretroviral Therapy Including FUZEONĀ® in the Treatment of Progressive Multifocal Leucoencephalopathy During HIV-1 Infection ANRS 125 TrialLeukoencephalopathy, Progressive Multifocal;HIV InfectionsDrug: Enfuvirtide;Drug: Tenofovir-EmtricitabineFrench National Agency for Research on AIDS and Viral HepatitisHoffmann-La Roche;Gilead SciencesCompleted18 YearsN/ABoth30Phase 2France